Baumer SA - Stock Quote BALM3
Morningstar's Baumer SA Stock Analysis
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Baumer SA's Company Profile
Baumer SA develops solutions in hospitals and health industry equipments. It has various segments like Orthopedic Implants, Biomaterials, Sterilization, Infections Control, Surgical Centers, Water Treatment & Solid residuals Health Treatment Divisions. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as fixation system locks, occipitocervial fixation systems, angled cervical cages, and posterior lumbar cages.